Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083694
Status:
COMPLETED
Last Update Posted:
2010-07-02
First Post:
2004-05-27
Brief Title:
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
Sponsor:
University of Arkansas
Organization:
University of Arkansas
Organization Data
Organization:
University of Arkansas
Class:
OTHER
Study ID:
UARK 98-032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Arkansas
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |